Peer Review History
| Original SubmissionMay 25, 2022 |
|---|
|
PONE-D-22-15117The relationship between a plant-based diet and mental health: evidence from a cross-sectional multicentric community trial (LIPOKAP Study)PLOS ONE Dear Dr. Mohammadifard, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 12 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohammad Hossein Ebrahimi Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Thank you for stating the following financial disclosure: This study has been funded by Pfizer company with grant number of 11531879. Dr Cesar de Oliveira is supported by the Economic and Social Research Council (ESRC) (grant ES/T008822/11). Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: This study received funding from Pfizer company (#11531879). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: This study has been funded by Pfizer company with grant number of 11531879. Dr Cesar de Oliveira is supported by the Economic and Social Research Council (ESRC) (grant ES/T008822/11). Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in your Competing Interests section: NO authors have competing interests Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Partly Reviewer #4: Yes Reviewer #5: Partly Reviewer #6: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: I Don't Know Reviewer #6: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: No Reviewer #6: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript describes the analysis of HADS and a semi-quantitative food frequency questionnaire in 2033 subjects from Iran. Several key aspects need a major revision (coherence between title, main aim and tools used: use of validated instruments; details of sample sizes for the different groups; adequate exploration of confounding variables; details of statistical analyses carried out; presentation of data, adequate discussion of hypotheses and findings; among others). Reviewer #2: Authors based on a relatively large cross-sectional analysis investigated the association of a priori food pattern i.e., PDI and its components with two mental disorders including anxiety and depression in Iran The following points are suggested Novelty of study should be declared. The first sentence in methods section should be revised. More details about the study population and sampling methods and generally about main study should be presented. More details about the validity and reliability of all instruments used in this study should be presented. More important: PDI as a priori pattern should be constructed in energy adjusted format then use it in association analysis The following sentence is not correct “The mean depression and anxiety scores across quartiles of PDI, hPDI, and uPDI were 8 169 compared in crude and multivariable-adjusted models by using Kruskal–Wallis and ANCOVA, 170 respectively.” Some important statistical analysis revision are required and should be presented revised analysis in results section. For selecting appropriate confounders it is needed to compare variable you have presented in table 1 and macro and micro nutrients between depressed and non-depressed and anxious and non-anxious , you should have table for such comparisons and select relevant confounders based on these comparisons and those you compared across quartiles of PDIs and redo the analyses. Due to gender difference based on both PDI scores and mental disorders subgroup analysis based on gender is necessary. Reviewer #3: Materials and Methods section need to be more elaborated with the clarification of the following issues: 1. It is not clear how the study divided food items into 21 main groups, and subsequently into three groups-animal sources, healthy, and unhealthy plant-based foods. 2. Validity and reliability of the food frequency questionnaire in local language is needed. 3. Was there any statistical basis for the sample size calculation? If so, then it should be mentioned. Reviewer #4: Summary of the research and overall impression The manuscript presents a detailed study in a relatively new area of research- exploring the relationship between plant- based diets and mental health. The promotion, prevention and treatment of mental health is recognized in the SDGs. The manuscript is technically sound, written in an intelligible fashion and in standard English. The statistical analysis has been performed appropriately and the data supports the conclusions. However, the minor areas of improvement raised below should be addressed to enhance the quality. Minor areas of Improvement Methods Mental Health Assessment- Line 158- please explain what informed the cut off of f ≤7 Discussion The sentence beginning on line 255 may need to be reviewed for it to be clearer. Discuss in simple and clear terms the implication of the findings to the practice of public health The manuscript would benefit from a spell-check and minor English copy-editing Reviewer #5: Kindly get it reviewed by a colleague who is not a co-author so that grammatical mistakes and punctuation could be corrected. Also refer to the reviewer comments in the attached pdf file and address those. Reviewer #6: 1. The authors state that nearly 13.1% of the individuals were excluded from the parent study (LIPOKAP). However, the has not been dealt explicitly in the discussion. 2. What do the authors mean by semi-quantitative food frequency questionnaire? Was a different FFQ used? If yes, kindly include in supplement. 3. Basis of categorisation of PDI into animal sources, healthy and unhealthy has not been explicitly explained. The reference no. 13 also does not clarify the doubt 4. Was the normality of data checked before using Krushkal Wallis test? 5. Authors have indicated in the introduction that existing literature lacks evidence on temporal association of PDI and depression / anxiety. However, in the discussion authors have tried to establish temporal association which cannot be done in a cross sectional type of study design 6. Overanalyses on the part of authors dealing on the beneficial effect of PDI can be noted. stating that the study population was healthy seems to be over exaggerated in the discussion. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No Reviewer #5: No Reviewer #6: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
The relationship between a plant-based diet and mental health: evidence from a cross-sectional multicentric community trial (LIPOKAP Study) PONE-D-22-15117R1 Dear Dr. Mohammadifard, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammad Hossein Ebrahimi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: (No Response) Reviewer #5: 1-If possible, provide references to the values of appropriate parameters used or at least to the formula used in sample size calculation. 2.The relationship between a plant-based diet and mental health: evidence from a cross-sectional multicentric community trial . IF CROSS-ECTIONAL is deleted then confusion about the design will be addressed. As your multicentric study is not cross-sectional. Also remove (LIPOKAP Study) from the title but do mention it in your Methodology. Your title may look like RELATIONSHIP BETWEEN A PLANT-BASED DIET AND MENTAL HEALTH-EVIDENCE FROM A MULTICENTRIC COMMUNITY TRIAL. Reviewer #6: The manuscript in its current form is suitable for publication. I thank the authors for addressing all the comments in an intelligent fashion by the peer reviewers. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: No Reviewer #5: No Reviewer #6: Yes: Aftab Ahmad ********** |
| Formally Accepted |
|
PONE-D-22-15117R1 The relationship between a plant-based diet and mental health: evidence from a cross-sectional multicentric community trial (LIPOKAP Study) Dear Dr. Mohammadifard: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohammad Hossein Ebrahimi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .